🇺🇸 progestins in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 12

Most-reported reactions

1. Completed Suicide — 4 reports (33.33%)
2. Arthralgia — 1 report (8.33%)
3. Asthenia — 1 report (8.33%)
4. Death — 1 report (8.33%)
5. Dizziness — 1 report (8.33%)
6. Headache — 1 report (8.33%)
7. Intracranial Pressure Increased — 1 report (8.33%)
8. Migraine — 1 report (8.33%)
9. Poisoning — 1 report (8.33%)

Source database →

Frequently asked questions

Is progestins approved in United States?

progestins does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for progestins in United States?

National Heart, Lung, and Blood Institute (NHLBI) is the originator. The local marketing authorisation holder may differ — check the official source linked above.